Form D · Biotechnology
Scholar Rock Holding Corp
Cambridge, MA · CIK 0001727196
Offering snapshot reported Jan 8, 2018 · SEC filing
- Reported sold
- $47M Offering amount: $47M
- Investors reported
- 19 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Dec 22, 2017 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jan 8, 2018 | Initial | $46,999,998 | No comparison | 19 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-302683
Amount sold shown in item 13 and number of investors shown in item 14 includes 5,559,286 from 2 non-US investors
Source: Form D, filed Jan 8, 2018. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Alan Buckler | Executive |
| Kristina Burow | Director |
| Yung H. Chyung | Executive |
| Elan Z. Ezickson | Executive |
| Jeffrey Flier | Director |
| Michael Gilman | Director |
| David Hallal | Director |
| Nagesh Mahanthappa | Director, Executive |
| Amir Nashat | Director |
| Timothy Springer | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
620 Memorial Drive, 2 Nd Floor
Cambridge, MA, 02139
Cambridge, MA, 02139